Health and Healthcare

ReShape Lifesciences : RSLS

RSLS

Stock Data

$6.40

$0.90 (16.36%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

ReShape Lifesciences Inc., a medical device company, provides products and services that manage and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company is headquartered in San Clemente, California.

All ReShape Lifesciences Articles

1 Article

Lee Jackson | Jun 19, 2021 at 6:15 AM EDT

4 Biotech and Life Sciences Stocks Trading Under $10 With Gigantic Upside Potential

These are four stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential.…